China unveils system for postmarket medical-device monitoring

09/10/2008 | FDAnews

China's State Food and Drug Administration has issued a white paper detailing the government's system for tracking adverse events linked to medical devices. Under the system, 10 national centers are in charge of registration testing of imported products and domestic products with Class III classification.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC